D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 99 Citations 34,534 709 World Ranking 5164 National Ranking 2865

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Gene

His primary areas of investigation include Radiation therapy, Cancer research, Nuclear medicine, Gemcitabine and Cancer. His Radiation therapy research incorporates elements of Lung cancer and Chemotherapy. His Cancer research research includes elements of In vitro, Biochemistry, Molecular biology, DNA repair and Cell cycle.

His studies in Nuclear medicine integrate themes in fields like Radiation treatment planning, Magnetic resonance imaging, Complication and Glioma. The various areas that Theodore S. Lawrence examines in his Gemcitabine study include Radiosensitizer, Pancreatic cancer, Urology, CHEK1 and Toxicity. The Cancer study combines topics in areas such as Melanoma, PARP1 and Oncology.

His most cited work include:

  • Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response (553 citations)
  • MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. (544 citations)
  • Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing (341 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Internal medicine, Cancer research, Radiation therapy, Oncology and Cancer. His work on Lung cancer, Toxicity and Biomarker as part of general Internal medicine study is frequently linked to In patient, bridging the gap between disciplines. His study on Cancer research also encompasses disciplines like

  • Pancreatic cancer and related Gemcitabine,
  • In vivo which intersects with area such as In vitro.

He combines subjects such as Chemotherapy, Nuclear medicine and Pathology with his study of Radiation therapy. His work deals with themes such as Radiation treatment planning, Magnetic resonance imaging and Glioma, which intersect with Nuclear medicine. The Radiology study which covers Hepatocellular carcinoma that intersects with Liver function.

He most often published in these fields:

  • Internal medicine (27.75%)
  • Cancer research (26.87%)
  • Radiation therapy (24.82%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (27.75%)
  • Cancer research (26.87%)
  • Radiation therapy (24.82%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Cancer research, Radiation therapy, Oncology and Radiology. Many of his studies on Internal medicine involve topics that are commonly interrelated, such as Gastroenterology. His Cancer research research is multidisciplinary, incorporating perspectives in Cancer, Pancreatic cancer, Immunotherapy, Cell culture and DNA repair.

Radiation therapy is a primary field of his research addressed under Surgery. The concepts of his Oncology study are interwoven with issues in Survival rate and Gemcitabine, Locally advanced pancreatic cancer, Chemotherapy. His work on Imaging biomarker as part of general Radiology study is frequently linked to Radiofrequency ablation, therefore connecting diverse disciplines of science.

Between 2016 and 2021, his most popular works were:

  • CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy (246 citations)
  • Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression (220 citations)
  • Cardiac events after radiation therapy: Combined analysis of prospective multicenter trials for locally advanced non-small-cell lung cancer (129 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

Theodore S. Lawrence mainly focuses on Radiation therapy, Cancer research, Internal medicine, Oncology and Radiology. His work carried out in the field of Radiation therapy brings together such families of science as Clinical endpoint, Proportional hazards model, Hazard ratio and Non small cell, Lung cancer. His research integrates issues of Cancer, Immune system, Immunotherapy, DNA damage and Reprogramming in his study of Cancer research.

His Oncology research includes themes of Biomarker, Triple-negative breast cancer, Locally advanced pancreatic cancer and Chemotherapy. His Radiology research includes themes of Hepatocellular carcinoma, Liver function, Carcinoma and Phases of clinical research. His Radiosurgery study integrates concerns from other disciplines, such as Lesion and Nuclear medicine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy

Weimin Wang;Michael Green;Jae Eun Choi;Miguel Gijón.
Nature (2019)

925 Citations

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.

Qing Ji;Xinbao Hao;Xinbao Hao;Min Zhang;Wenhua Tang.
PLOS ONE (2009)

818 Citations

Analysis of radiation-induced liver disease using the Lyman NTCP model.

Laura A. Dawson;Daniel Normolle;James M. Balter;Cornelius J. McGinn.
International Journal of Radiation Oncology Biology Physics (2002)

808 Citations

Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response

Bradford A. Moffat;Thomas L. Chenevert;Theodore S. Lawrence;Charles R. Meyer.
Proceedings of the National Academy of Sciences of the United States of America (2005)

756 Citations

Hepatic toxicity resulting from cancer treatment

Theodore S. Lawrence;John M. Robertson;Mitchell Steven Anscher;Randy L. Jirtle.
International Journal of Radiation Oncology Biology Physics (1995)

740 Citations

Transmission of hormonal stimulation by cell-to-cell communication.

Theodore S. Lawrence;William H. Beers;Norton B. Gilula.
Nature (1978)

600 Citations

Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing

James M. Balter;Randall K. Ten Haken;Theodore S. Lawrence;Kwok L. Lam.
International Journal of Radiation Oncology Biology Physics (1996)

517 Citations

Profiling of Cancer Cells Using Protein Microarrays Discovery of Novel Radiation-regulated Proteins

Arun Sreekumar;Mukesh K. Nyati;Sooryanarayana Varambally;Terrence R. Barrette.
Cancer Research (2001)

458 Citations

Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients

Mary Kaye Martel;Randall K. Ten Haken;Mark B. Hazuka;Marc L. Kessler.
Lung Cancer (1999)

448 Citations

Escalated Focal Liver Radiation and Concurrent Hepatic Artery Fluorodeoxyuridine for Unresectable Intrahepatic Malignancies

Laura A. Dawson;Cornelius J. McGinn;Daniel Normolle;Randall K. Ten Haken.
Journal of Clinical Oncology (2000)

445 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Theodore S. Lawrence

Laura A. Dawson

Laura A. Dawson

Princess Margaret Cancer Centre

Publications: 120

Randall K. Ten Haken

Randall K. Ten Haken

University of Michigan–Ann Arbor

Publications: 81

Brian D. Ross

Brian D. Ross

University of Michigan–Ann Arbor

Publications: 73

Yi Sun

Yi Sun

Zhejiang University

Publications: 52

Dirk De Ruysscher

Dirk De Ruysscher

Maastricht University

Publications: 49

Lawrence B. Marks

Lawrence B. Marks

University of North Carolina at Chapel Hill

Publications: 48

Thomas Brunner

Thomas Brunner

University of Konstanz

Publications: 44

Christopher H. Crane

Christopher H. Crane

Memorial Sloan Kettering Cancer Center

Publications: 44

Kevin J. Harrington

Kevin J. Harrington

Royal Marsden NHS Foundation Trust

Publications: 42

Joseph M. Herman

Joseph M. Herman

National Cancer Institute

Publications: 40

Timothy J. Kinsella

Timothy J. Kinsella

Brown University

Publications: 40

Robert A. Wolff

Robert A. Wolff

The University of Texas MD Anderson Cancer Center

Publications: 36

Zhongxing Liao

Zhongxing Liao

The University of Texas MD Anderson Cancer Center

Publications: 33

Philippe Lambin

Philippe Lambin

Maastricht University

Publications: 33

Avraham Eisbruch

Avraham Eisbruch

University of Michigan–Ann Arbor

Publications: 32

C. Clifton Ling

C. Clifton Ling

Memorial Sloan Kettering Cancer Center

Publications: 31

Trending Scientists

King Ngi Ngan

King Ngi Ngan

University of Electronic Science and Technology of China

Chris F. Kemerer

Chris F. Kemerer

University of Pittsburgh

Pedatsur Neta

Pedatsur Neta

National Institute of Standards and Technology

Luísa M. D. R. S. Martins

Luísa M. D. R. S. Martins

Instituto Superior Técnico

Kazuo Moriwaki

Kazuo Moriwaki

National Institute of Genetics

Samuel E. Lux

Samuel E. Lux

Harvard University

Marcelo Jacobs-Lorena

Marcelo Jacobs-Lorena

Johns Hopkins University

Thomas J. Louie

Thomas J. Louie

University of Calgary

Francisco Javier Sierro

Francisco Javier Sierro

University of Salamanca

Pierre Payment

Pierre Payment

Institut National de la Recherche Scientifique

Anthony C. Withers

Anthony C. Withers

University of Western Ontario

Dimiter S. Dimitrov

Dimiter S. Dimitrov

University of Pittsburgh

David M. Fresco

David M. Fresco

University of Michigan–Ann Arbor

Martin M. Brown

Martin M. Brown

University College London

Alicia Ely Yamin

Alicia Ely Yamin

Harvard University

Katja Beesdo-Baum

Katja Beesdo-Baum

TU Dresden

Something went wrong. Please try again later.